Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (111-120 of 279) with videos related to

Pageof 28
Sort By:
Leukemia|April 15, 2025
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxAlexandra Niedermayer, Jana Stursberg, Anke Katharina Bergmann, et al.
Haematologica|August 10, 2014
Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphomaHeike Thorer, Martin Zimmermann, Olga Makarova, et al.
Blood|October 18, 2002
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalitiesChristian M Zwaan, Gertjan J L Kaspers, Rob Pieters, et al.
Leukemia & Lymphoma|July 10, 2014
Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study GroupThies Bartram, Birgit Burkhardt, Wilhelm Wössmann, et al.
Therapeutic Drug Monitoring|February 6, 2020
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 StudyGudrun Würthwein, Claudia Lanvers-Kaminsky, Joachim Gerss, et al.
Cancer|August 17, 2016
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsUrsula Creutzig, Martin Zimmermann, Dirk Reinhardt, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphomaIdoia Martin-Guerrero, Itziar Salaverria, Birgit Burkhardt, et al.
Pediatric Blood & Cancer|April 12, 2011
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Cancers|April 12, 2022
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?Christine Damm-Welk, Federica Lovisa, Giorgia Contarini, et al.
British Journal of Haematology|June 24, 2017
Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescentsMonika Szczepanowski, Jonas Lange, Christian W Kohler, et al.
Pageof 28

Showing results (111-120 of 279) with videos related to

Sort By:
Pageof 28
Leukemia|April 15, 2025
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxAlexandra Niedermayer, Jana Stursberg, Anke Katharina Bergmann, et al.
Haematologica|August 10, 2014
Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphomaHeike Thorer, Martin Zimmermann, Olga Makarova, et al.
Blood|October 18, 2002
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalitiesChristian M Zwaan, Gertjan J L Kaspers, Rob Pieters, et al.
Leukemia & Lymphoma|July 10, 2014
Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study GroupThies Bartram, Birgit Burkhardt, Wilhelm Wössmann, et al.
Therapeutic Drug Monitoring|February 6, 2020
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 StudyGudrun Würthwein, Claudia Lanvers-Kaminsky, Joachim Gerss, et al.
Cancer|August 17, 2016
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsUrsula Creutzig, Martin Zimmermann, Dirk Reinhardt, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphomaIdoia Martin-Guerrero, Itziar Salaverria, Birgit Burkhardt, et al.
Pediatric Blood & Cancer|April 12, 2011
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Cancers|April 12, 2022
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?Christine Damm-Welk, Federica Lovisa, Giorgia Contarini, et al.
British Journal of Haematology|June 24, 2017
Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescentsMonika Szczepanowski, Jonas Lange, Christian W Kohler, et al.
Pageof 28